Nitric oxide (NO) in combination with superoxide produces peroxynitrites and induces protein nitration, which participates in a number of chronic degenerative diseases. NO is produced at high levels in the human emphysematous lung, but its role in this disease is unknown. The aim of this study was to determine whether the NO synthases contribute to the development of elastase-induced emphysema in mice. nNOS, iNOS, and eNOS were quantified and immunolocalized in the lung after a tracheal instillation of elastase in mice. To determine whether eNOS or iNOS had a role in the development of emphysema, mice bearing a germline deletion of the eNOS and iNOS genes and mice treated with a pharmacological iNOS inhibitor were exposed to elastase. Protein nitration was determined by immunofluorescence, protein oxidation was determined by ELISA. Inflammation and MMP activity were quantified by cell counts, RT-PCR and zymography in bronchoalveolar lavage fluid. Cell proliferation was determined by Ki67 immunostaining. Emphysema was quantified morphometrically. iNOS and eNOS were diffusely upregulated in the lung of elastase-treated mice and a 12-fold increase in the number of 3-nitrotyrosine-expressing cells was observed. Over 80% of these cells were alveolar type 2 cells. In elastaseinstilled mice, iNOS inactivation reduced protein nitration and increased protein oxidation but had no effect on inflammation, MMP activity, cell proliferation or the subsequent development of emphysema. eNOS inactivation had no effect. In conclusion, in the elastase-injured lung, iNOS mediates protein nitration in alveolar type 2 cells and alleviates oxidative injury. Neither eNOS nor iNOS are required for the development of elastase-induced emphysema.
Free radical toxicity is one of the main contributors to the development of pulmonary emphysema, a frequent chronic degenerative disease of the lung characterized by reduced maximal expiratory flow, increased lung volume, and alveolar wall destruction. This phenomenon has been well demonstrated with regard to the role of reactive oxygen species, and in particular the superoxide anion [1] [2] [3] pertaining to the concept of oxidative stress. By analogy, a similar role has been suspected to be played by nitrogen reactive species, and in particular by nitric oxide (NO), pertaining to the concept of nitrosative stress.
NO is the principal reactive nitrogen species encountered in vivo. It is produced from L-arginine by the neuronal, endothelial, and inducible isoforms of the NO synthase (nNOS, iNOS, and eNOS). In addition to its multiple physiological properties, NO at high concentrations exerts toxicity through its combination with superoxide anion to form peroxynitrite (ONOO K À ). ONOO K À in turn induces nitration of lipids, nucleic acids, and proteins, distorting their structure and altering their function. Peroxynitritemediated cytotoxycity has a key role in the pathogenesis of a number of chronic degenerative diseases of the brain, heart, and liver. 4 Several clues suggest a role for NO and the NOS in the course of pulmonary emphysema. Increased levels of alveolar NO are measured in patients with severe chronic obstructive pulmonary disease, 5 whereas protein nitration is detected in the airway of such patients. 6 In line with these results, the expression of iNOS is exaggerated and is correlated with the extent of protein nitration in the alveolar walls of patients with pulmonary emphysema. 7 However, although markers of nitrosative stress are present in the lung of patients with emphysema, leading some authors to suggest a role for this phenomenon in the process of disease 6, [8] [9] [10] ; the relationship between nitrosative stress and the development of emphysema is unknown.
To clarify this point, we sought to determine whether NOS isoforms had a role in an animal model of emphysema. First, we determined the level of nNOS, iNOS, and eNOS expression as well as the extent of protein nitration in the lung of mice after a tracheal instillation of elastase, a well-documented model of experimental emphysema. Second, we determined whether inactivation of iNOS or eNOS influenced markers of nitrosative and oxidative stress, inflammation, protease activity and the development of emphysema in the lung following elastase instillation.
MATERIALS AND METHODS Animal Model
Male 8-week-old mice of C57BL/6 background were anesthetized and received a tracheal instillation of saline or 5 U of porcine pancreatic elastase (EC134, Elastin Products, Owensville, MO, USA) as previously described. 11 In some experiments, iNOS À/À and eNOS À/À animals were used, with wild-type C57BL/6 mice as controls (Jackson Laboratory, Bar Harbor, ME, USA). In other experiments, wild-type mice (Janvier, Le Genest Saint-Isle, France) were treated subcutaneously with two injections of 10 mg/kg (20 mg/kg/ day) N-3-aminomethyl-benzyl-acetamidine-dihydrochloride (1400W, Cayman Chemical, Ann Arbor, MI, USA), a specific iNOS inhibitor, 12 from the day before tracheal instillation to the day they were killed, whereas control mice received saline injections. Another experiment was conducted with daily 1400W at 1 mg/kg/day. In other experiments, Balb/c mice (Janvier) were used. Studies were conducted in compliance with INSERM guidelines regarding the fair treatment of animals, under a license from the French administration to conduct animal research as described in the protocol.
Determination of nNOS, iNOS, and eNOS mRNA and Protein Levels in Lung Homogenate
Total mRNA was prepared from the crushed lung of the different mice, using RNeasy Protect Mini Kit (Qiagen, ZA Courtaboeuf, France) following the manufacturer's protocol. First-strand cDNA was synthesized in RT samples, each containing: 2.5 mg total RNA isolated from cells, 8 U/ml M-MLV reverse transcriptase (Gibco-BRL, Life Technologies, Cergy-Pontoise, France), 4 mM Oligo-(dT) 12-18 (Invitrogen, Cergy-Pontoise, France), and 0.8 mM mixed dNTP (GE Healthcare, Saclay, France). Quantitative PCR was performed in a 7900HT Real-Time PCR system (Applied Biosystems, ZA Courtaboeuf, France), using Fast SYBR Master Mix from Applied Biosystems. The sequences of primers are indicated in Supplementary Table 1 . Normalization was achieved by quantification of the expression of either CXXC1 or ribosomal protein 13 mRNA (RPL13) as described previously, 11 chosen as control housekeeping genes (HKG) among four HKG tested because of their stable expression in the different conditions of the experiment (KO iNOS and 1400W-treated mice with or without tracheal instillation of elastase), and/or their adequate expression level as compared with the considered target gene. All PCR conditions were adjusted in order to obtain equivalent optimal amplification efficiency between the different assays. Mice's lung mRNA expression were quantified by relative quantification (DDCT method) according to Pfaffl et al 13 using an equal mix of each cDNA sample from the different mice's lung, as calibrator sample. All PCR experiments were done in triplicate.
iNOS, nNOS, and eNOS lung protein levels were determined at day 7 after instillation by western blot analysis using 100 mg protein with antibodies binding iNOS (VPA5382 Abcys, Paris, France), eNOS and nNOS (610296 and 610309, BD Transduction Laboratories, San Jose, CA, USA) diluted 1/1000. b-Actin (A2228, Sigma, St Louis, MO, USA) was used as an internal control.
Localization of iNOS and eNOS Expression in the Lung
The expression of iNOS and eNOS was localized by confocal microscopy on 5 mm-thick frozen lung sections permeabilized with 0.1% Triton Â 100 (Sigma) using rabbit anti-iNOS (VPA5382, Abcys, diluted 1/500 for 1 h at 371C) and antieNOS (610298, BD Transduction Laboratories, diluted 1/25 for 1 h at 371C) antibodies, with normal rabbit serum (Vector, Peterborough, UK) as a control, revealed with a goat Alexa fluor 546-conjugated anti-rabbit secondary antibody (A11010, Molecular Probes, Eugene, OR, USA). Alveolar type 2 cells were localized with a rabbit anti-proSFTPC antibody (AB3786, Chemicon, Temecula, CA, USA, diluted 1/250 for 1 h at 371C) and revealed with the Zenon Rabbit IgG Labeling Kit Alexa fluor 488 (Z-25302, Molecular Probes). Macrophages were detected with a rat anti-MAC3 antibody (550292, BD Pharmingen, diluted 1/750 for 1 h at room temperature) and revealed with a goat Alexa fluor 488-conjugated anti-rat secondary antibody (A-11006, Molecular Probes). Nuclei were stained with TO-PRO-3 (Molecular Probes). Slides were examined with an LSM-510-META confocal laser scanning microscope (Zeiss, Oberkochen, Germany).
Quantification and Localization of Nitrated Proteins in the Lung
The accumulation in the lung of 3-nitrotyrosine, a marker of protein nitration, was determined by immunofluorescence microscopy on frozen lung sections using a rabbit anti-3-nitrotyrosine polyclonal antibody (05-233, Upstate NO synthases in elastase-induced emphysema L Boyer et al biotechnology, Temecula, CA, USA, diluted to 0.5 mg/ml for 1 h at 371C) and revealed with a goat Alexa fluor 546-conjugated anti-rabbit secondary antibody (A11010, Molecular Probes). The accumulation of 3-nitrotyrosine in the lung was quantified by counting the number of 3-nitrotyrosineexpressing cells in 10 microscopic fields per slide at Â 20 magnification using a Zeiss Axiophot fluorescence microscope.
Double immunostaining confocal microscopy experiments were performed as described above to determine the type of 3-nitrotyrosine-expressing cells. The number of doublestained cells was reported to the number of proSFTPCpositive or MAC3-positive cells and was expressed as a percentage.
Quantification of Oxidative Stress Markers in the Lung
Oxidized protein levels were determined in total lung homogenate by ELISA using the OxiSelect Protein Carbonyl ELISA kit (STA-310, Cell Biolabs, San Diego, CA, USA). Heme Oxygenase 1 (HO1) mRNA was quantified in lung homogenate by RT-PCR as described above. The sequences of primers are indicated in Supplementary Table 1 .
Quantification of Pulmonary Inflammation and Protease Activity
The intensity of the pulmonary inflammatory reaction was assessed in bronchoalveolar lavage fluid (BALF). Lungs were lavaged with 2 ml saline, and cells were differentially counted with the Diff-Quick stain (Baxter-Dade AG, Dudingen, Germany). The concentration in BALF of the chemoattractant chemokine CCL2 was determined by ELISA (R&D Systems, Lille, France). Gelatin zymography was performed on BALF as described previously. 11 To explore the effect of iNOS inactivation on the mechanisms driving lung inflammation in this model, we quantified the expression of CCL2, CXCL2, tumor necrosis factor-a (TNFa), and interleukin-6 (IL6) mRNAs normalized by CXXC1 mRNA, as described above. The sequences of primers are indicated in Supplementary Table 1. CCL2 protein levels were determined in BALF by ELISA (R&D Systems).
Determination of Ki67 Expression in the Lung
The accumulation in the lung of Ki67, a cell cycle related nuclear protein expressed by proliferating cells, was determined by immunohistochemistry on frozen lung sections using a rabbit ki67 polyclonal antibody (Ab66155, Abcam, MA, USA, diluted 1/300, overnight at 41C) and revealed with the Vectastain ABC-peroxydase kit system (PK 4001, Vector Laboratories, CA, USA). The number of Ki67-positive cells was counted in 10 microscopic fields at Â 20 magnification and expressed as a percentage.
Morphological Analysis
The lungs were fixed with 2.5% glutaraldehyde at a transpleural pressure of 25 cmH 2 O for 3 h and held in 4% paraformaldehyde (Sigma). Great-axis sagittal sections (5 mm) of the left lung were cut in a systematic manner and were stained with hematoxylin and eosin. Five blackand-white digital photomicrographs were acquired from the cranial, medial, and caudal regions of each slide at Â 100 magnification, excluding areas where large bronchi or vessels predominated, resulting in a total of 15 images per lung. Emphysema was then quantified by measurement of the mean chord length of alveoli with Analysis software (Soft Imaging System, Münster, Germany) at a 5-mm interval. This automated analysis was made vertically and horizontally on each photomicrograph. The mean chord length of alveoli was obtained by averaging those measurements.
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Statistical Analysis Data were expressed as means±s.e. and were analyzed with GraphPad Prism 4.0 (La Jolla, CA, USA). Comparisons between multiple groups were performed with Kruskall-Wallis' non-parametric analysis of variance test followed when a difference was detected by two-by-two comparisons with Mann-Whitney's U test. P-values o0.05 were considered significant.
RESULTS Elastase Induced the Pulmonary Expression of iNOS and eNOS
Elastase instillation induced a marked increase in lung iNOS mRNA (Figure 1a ). This increase was present from day 1 post-instillation, reached a maximum on day 7, and persisted to day 20. This increase in iNOS mRNA in elastase-treated mice translated into a 433% increase in the pulmonary content of iNOS protein as assessed by western blotting in lung homogenate at day 7 (P ¼ 0.002).
In comparison to control mice, eNOS mRNA was significantly increased in the lungs of elastase-treated mice from day 1 to day 20, peaking at day 1 and decreasing thereafter (Figure 1b) . Accordingly, a 380% increase in eNOS protein was observed in the lung of those animals at day 7 (P ¼ 0.016).
Lung nNOS mRNA was decreased at days 1 and 7 following elastase instillation (Figure 1c) . nNOS protein levels in lung homogenate of those mice were similar to those observed in control animals.
Confocal microscopy analysis was performed to determine which cell types were responsible for the increased expression of eNOS and iNOS in the elastase-injured lung. iNOS and eNOS were expressed at low levels in the lungs of control mice. In elastase-induced mice, iNOS was diffusely expressed in alveolar walls. Colocalization experiments showed that iNOS was expressed by 80.5 ± 7.8% of macrophages, identified by MAC3 staining, as well as 42.3 ± 8.6% of alveolar type 2 cells, identified by proSFTPC staining (Figure 2) . Likewise, eNOS expression was diffuse and involved both macrophages and alveolar type 2 cells (respectively, 81.5±0.7% and 14.7±4.8% of these cells expressed eNOS). iNOS Deletion Abolished Elatase-Induced Lung Protein Nitration but Did Not Prevent Emphysema We then aimed to determine whether eNOS or iNOS were required for the accumulation of nitrated proteins and the development of emphysema in the elastase-injured lung. Protein nitration and emphysema were not attenuated in eNOS À/À mice compared with wild-type mice at day 7 after elastase instillation. In iNOS À/À mice, the number of 3-nitrotyrosine-positive cells was reduced by 62% compared with wild-type animals (P ¼ 0.04); this effect was not associated with a reduction in the severity of emphysema in iNOS À/À mice. Although the mean chord length of alveoli was markedly increased in elastase mice compared with the control group (33.2 mm ± 4.6 vs 21.5 mm ± 0.9; P ¼ 0.04), iNOS inactivation did not modify the elastase-induced increase in this parameter (32.5 mm ± 5.9, P ¼ 0.99 vs elastase) (Figure 4a-c) .
Pharmacological Inhibition of iNOS Reproduced the Phenotype of iNOS À/À Mice To control for compensatory mechanisms induced during development by germline deletion of the iNOS gene, wildtype mice were treated with 1400W, a specific iNOS inhibitor. At a dose of 20 mg/kg/day, 1400W reduced by 72% the number of 3-nitrotyrosine-positive cells in the lung of elastase-instilled mice (P ¼ 0.042, Figure 4d ). However, as was observed with iNOS À/À mice, this major reduction in lung protein nitration did not translate into a reduction in elastase-induced emphysematous changes (42.6 mm ± 3.5 vs 38.0 mm ± 2.9, P ¼ 0.45) (Figure 4e) . Similarly, 1400W at a dose of 1 mg/kg/day did not reduce emphysema in elastaseinstilled C57B/6 mice (results not shown). To control bias relative to the choice of the C57B/6 strain for our experiments, Balb/c mice were used. As was observed in C57B/6 mice, 1400W had no protective effect against emphysema in Balb/c mice (results not shown).
iNOS Inhibition Increased Markers of Oxidative Stress After Elastase Instillation
As iNOS-derived peroxynitrite increases superoxide production in mitochondria, 14 we determined whether iNOS inhibition would modulate the level of oxidative stress in the NO synthases in elastase-induced emphysema L Boyer et al lung at day 7 after elastase instillation. Although elastase exposure alone did not increase protein carbonylation in the lung, a 141% increase in protein carbonylation was observed in iNOS À/À compared with wild-type mice after elastase instillation (P ¼ 0.032, Figure 5a ). Consistently with this result, 1400W induced a 229% increase in protein carbonylation at day 7 after elastase instillation (P ¼ 0.002, Figure  5b ). By contrast, the induction at day 1 after elastase instillation of HO1 gene expression, another marker of oxidative stress, was not influenced by iNOS deletion (Figure 5c ) or pharmacological inhibition (Figure 5d ).
iNOS Inhibition Did Not Reduce Inflammation, MMP Activity or Alveolar Cell Proliferation After Elastase Instillation Nitrotyrosine accumulation can be induced by neutrophil myeloperoxidase, 15 and the inactivation of iNOS has been shown to reduce inflammation in models of lung injury. 16, 17 Thus, we tested the hypothesis that 1400W may have reduced the accumulation of nitrotyrosine-positive material in the lung through a reduction in pulmonary inflammation. The influx in BALF of neutrophils (Figure 6a ) or macrophages ( Figure 6b) were not reduced in iNOS À/À compared with wild-type mice at day 1 or day 7 after elastase instillation. Consistently with the lack of an anti-inflammatory effect of iNOS deletion, the pulmonary levels of CCL2, CXCL2, TNFa, and IL6mRNAs were not different in elastase-instilled iNOS À/À and wild-type animals (Figure 6c-f) . Similarly, pharmacological inhibition of iNOS neither reduced inflammatory cell counts, cytokine mRNAs ( Supplementary  Figure 1) , or BALF CCL2 protein levels after elastase instillation (Supplementary Figure 2a) , nor influenced the activity of MMP2 and MMP9, the main MMPs expressed, respectively, by macrophages and neutrophils, in BALF of elastase-instilled mice (Supplementary Figure 2b, c, and d ). An 85% increase in alveolar cell proliferation was observed in the lung of elastase-instilled wild-type animals compared with saline-instilled mice. Treatment with 1400W did not increase or decrease elastase-induced alveolar cell proliferation (Supplementary Figure 3) . 
DISCUSSION
The main results of this study are (1) that iNOS and eNOS were diffusely induced in the mouse lung following a tracheal instillation of elastase, (2) that the induction of iNOS in the lung caused the accumulation of nitrated proteins in alveolar type 2 cells and to a lesser extent in macrophages, (3) that iNOS activity was not required for elastase-induced pulmonary inflammation, (4) that iNOS inactivation increased the level of oxidative stress in the elastase-instilled lung, and (5) that inactivation of eNOS or iNOS did not protect against elastase-induced emphysema. These findings provide evidence that iNOS-dependent protein nitration in alveolar type 2 cells accompanies but is not necessary for the development of elastase-induced pulmonary emphysema in mice. Increases in lung iNOS expression and protein nitration were previously described in the lungs of patients with COPD 7 as well as in experimental emphysema induced by inhibition of the VEGF receptor or surfactant protein D deficiency 18, 19 ; whether these phenomena contributed to airspace enlargement in these models was not reported, but could be suspected as iNOS contributes to inflammation and tissue remodeling in other models of lung injury such as endotoxin-induced pneumonitis, 17 ventilator-induced lung injury, 16 and silica-induced pulmonary fibrosis. 20 In contrast with these observations, we observed that, whereas iNOS was strongly induced in the lung following elastase instillation, iNOS inhibition had no evident impact on pulmonary inflammation or emphysema development in this model. eNOS was not implicated neither in lung protein nitration nor in the development of emphysema following a tracheal instillation of elastase; deletion of eNOS was not deleterious either, although eNOS promotes compensatory alveologenesis after pneumonectomy. 21 nNOS has been reported to be induced and/or to contribute to pulmonary inflammation in experimental models of lung disease, 22, 23 and it was surprising that this isoform was not induced in our model. Elastase-induced emphysema is an artificial model that does not reproduce any and all features of smoke-induced COPD. Bronchial and small airway alterations, which are observed in the development of centrilobular emphysema in NO synthases in elastase-induced emphysema L Boyer et al humans, 24 are not reproduced by this model. However, elastase instillation in rodents reproduces key phenomena conducting to alveolar walls destruction and air space enlargement, which define lesions of emphysema. 25 In our experiments, elastase instillation in mice reproduced the pattern of iNOS induction and protein nitration observed in the lung of patients with emphysema. 7, 26 Our observation that eNOS was also induced in the lung after elastase instillation was in line with the expression in COPD of constitutive NOS isoforms, as evidenced by the partial inhibition of alveolar NO production by inhaled aminoguanidine, a specific iNOS inhibitor, in these patients. 10 Strengthening the relevancy of our model, the NOS expression profile induced by elastase instillation in our experiments was identical to that induced by cigarette smoke exposure in rats. 27 Activity of all NOS isoforms can be regulated post-translationally, 10, 28 and it might be hypothesized that the lack of effect of eNOS or iNOS inactivation be related to already low levels of eNOS or iNOS activity. This question is of particular concern in the case of eNOS because we did not observe any morphological or biochemical effect of eNOS deletion. Our results, however, suggest that iNOS was indeed active in the elastase-injured lung, as iNOS inactivation was consistently associated with reduced nitration of lung proteins, a phenomenon directly linked to NO production. 4 Neutrophil myeloperoxidase can induce protein nitration in the presence of nitrite and hydrogen peroxide. 15 The fact that iNOS inactivation reduced elastase-induced protein nitration in the absence of a reduction in neutrophil counts pleads against the hypothesis that myeloperoxidase was a major contributor to protein nitration in our experiments.
The role of NO synthases in the distal lung remains unclear. The observation that protein carbonyls, a marker of oxidative stress, were increased in the lungs of iNOS À/À and NO synthases in elastase-induced emphysema L Boyer et al 1400W-treated animals suggested that iNOS had an antioxidative role. Whether this effect was exerted through quenching of superoxide by NO or through a reduction in superoxide production was beyond the scope of this study, although the identical levels of HO1 gene expression in iNOS À/À and 1400W-treated animals compared with controls suggested that the production of oxygen reactive species was similar in all groups of animals. A detrimental increase in NO synthases in elastase-induced emphysema L Boyer et al oxidative stress may have counterbalanced a putatively beneficial reduction in nitrosative stress in our model, resulting in a net null effect of iNOS deletion and inhibition. The preservation of alveolar cell proliferation in iNOS À/À and 1400W-treated animals suggests that iNOS is not critical to alveolar repair.
In contrast with iNOS expression, which was diffuse in the alveolar wall, 3-nitrotyrosine staining mostly involved alveolar type 2 cells. Given that protein nitration reflects not only NO but also superoxide production, this finding indicates alveolar type 2 cells as the main cellular source of superoxide in alveolar walls in this model. Indeed, alveolar type 2 cells express NADPH oxidase and xanthine oxidase and are an important source of superoxide in the lung. 29, 30 Alternatively, the accumulation of nitrated proteins in alveolar type 2 cells may reflect a constitutive or elastase-induced vulnerability of these cells to nitrosative stress.
Interestingly, the absence of a cause and effect relationship between iNOS-dependent protein nitration and tissue destruction may be a general feature of models of elastaseinduced disease in elastin-rich organs, as similar results were reported in the elastase-induced abdominal aortic aneurysm model. iNOS and 3-nitrotyrosine expression are increased in human abdominal aortic aneurysms, 31 as well as in the aorta of mice after elastase exposure. Similarly to our findings, elastase-induced aneurismal dilatation of the aorta is not reduced in iNOS À/À mice, even though accumulation of 3-nitrotyrosine is greatly reduced. 32 Pulmonary emphysema and aortic aneurysms may be closely related diseases from a pathophysiological standpoint.
Strong data support a critical role of excess oxygen reactive species, or oxidative stress, in the course of experimental emphysema, [1] [2] [3] 33 which led to ask whether other reactive species would have a similar role in this disease. This study showed that iNOS, eNOS, and nitration of lung proteins were not required for the development of elastase-induced emphysema, suggesting that excess nitrogen reactive species may not be important players in the development of pulmonary emphysema.
